Literature DB >> 19095658

A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation.

Yongqiang Wang1, Mingxiang Liao, Nicholas Hoe, Poulomi Acharya, Changhui Deng, Andrew N Krutchinsky, Maria Almira Correia.   

Abstract

Cytochromes P450 (P450s) incur phosphorylation. Although the precise role of this post-translational modification is unclear, marking P450s for degradation is plausible. Indeed, we have found that after structural inactivation, CYP3A4, the major human liver P450, and its rat orthologs are phosphorylated during their ubiquitin-dependent proteasomal degradation. Peptide mapping coupled with mass spectrometric analyses of CYP3A4 phosphorylated in vitro by protein kinase C (PKC) previously identified two target sites, Thr(264) and Ser(420). We now document that liver cytosolic kinases additionally target Ser(478) as a major site. To determine whether such phosphorylation is relevant to in vivo CYP3A4 degradation, wild type and CYP3A4 with single, double, or triple Ala mutations of these residues were heterologously expressed in Saccharomyces cerevisiae pep4Delta strains. We found that relative to CYP3A4wt, its S478A mutant was significantly stabilized in these yeast, and this was greatly to markedly enhanced for its S478A/T264A, S478A/S420A, and S478A/T264A/S420A double and triple mutants. Similar relative S478A/T264A/S420A mutant stabilization was also observed in HEK293T cells. To determine whether phosphorylation enhances CYP3A4 degradation by enhancing its ubiquitination, CYP3A4 ubiquitination was examined in an in vitro UBC7/gp78-reconstituted system with and without cAMP-dependent protein kinase A and PKC, two liver cytosolic kinases involved in CYP3A4 phosphorylation. cAMP-dependent protein kinase A/PKC-mediated phosphorylation of CYP3A4wt but not its S478A/T264A/S420A mutant enhanced its ubiquitination in this system. Together, these findings indicate that phosphorylation of CYP3A4 Ser(478), Thr(264), and Ser(420) residues by cytosolic kinases is important both for its ubiquitination and proteasomal degradation and suggest a direct link between P450 phosphorylation, ubiquitination, and degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095658      PMCID: PMC2645824          DOI: 10.1074/jbc.M806104200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

2.  Phosphorylation of cytochrome P4502E1 (CYP2E1) by calmodulin dependent protein kinase, protein kinase C and cAMP dependent protein kinase.

Authors:  J F Menez; T K Machu; B J Song; M D Browning; R A Deitrich
Journal:  Alcohol Alcohol       Date:  1993-07       Impact factor: 2.826

3.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.

Authors:  K Brown; S Gerstberger; L Carlson; G Franzoso; U Siebenlist
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

4.  Substrate-regulated, cAMP-dependent phosphorylation, denaturation, and degradation of glucocorticoid-inducible rat liver cytochrome P450 3A1.

Authors:  E Eliasson; S Mkrtchian; J R Halpert; M Ingelman-Sundberg
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

5.  Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

Authors:  S Miyamoto; M Maki; M J Schmitt; M Hatanaka; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates.

Authors:  Y Dai; J Rashba-Step; A I Cederbaum
Journal:  Biochemistry       Date:  1993-07-13       Impact factor: 3.162

7.  Purification and characterization of two membrane bound serine proteinases from rat liver microsomes active in degradation of cytochrome P450.

Authors:  A Zhukov; V Werlinder; M Ingelman-Sundberg
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

8.  Evidence against a role for serine 129 in determining murine cytochrome P450 Cyp2e-1 protein levels.

Authors:  J E Freeman; C R Wolf
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

9.  Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1.

Authors:  B J Roberts; B J Song; Y Soh; S S Park; S E Shoaf
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

10.  Endocytosis and degradation of the yeast uracil permease under adverse conditions.

Authors:  C Volland; D Urban-Grimal; G Géraud; R Haguenauer-Tsapis
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

View more
  20 in total

Review 1.  CHIP and gp78-mediated ubiquitination of CYP3A4: Implications for the pharmacology of anticancer agents.

Authors:  Cody J Peer; Tristan M Sissung; William D Figg
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

2.  Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol.

Authors:  Poulomi Acharya; Mingxiang Liao; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

Review 3.  Unusual properties of the cytochrome P450 superfamily.

Authors:  David C Lamb; Michael R Waterman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

4.  Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Dennis R Koop; Yi Liu; Mingxiang Liao; Alma L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 5.  Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Authors:  Ignat Printsev; Daniel Curiel; Kermit L Carraway
Journal:  J Membr Biol       Date:  2016-10-14       Impact factor: 1.843

Review 6.  Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Authors:  Sung-Mi Kim; YongQiang Wang; Noushin Nabavi; Yi Liu; Maria Almira Correia
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

7.  The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions.

Authors:  Ji Won Park; James R Reed; Wayne L Backes
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

8.  Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.

Authors:  Sung-Mi Kim; Poulomi Acharya; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-09-06       Impact factor: 5.157

9.  Multisite phosphorylation of human liver cytochrome P450 3A4 enhances Its gp78- and CHIP-mediated ubiquitination: a pivotal role of its Ser-478 residue in the gp78-catalyzed reaction.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Yi Liu; Ranjit K Thirumaran; Relly Brandman; Erin G Schuetz; Alma L Burlingame; Maria Almira Correia
Journal:  Mol Cell Proteomics       Date:  2011-11-17       Impact factor: 5.911

10.  Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes.

Authors:  YongQiang Wang; Sung-Mi Kim; Michael J Trnka; Yi Liu; A L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.